Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01641 |
| Species: | Homo sapiens |
| Position : | chr11:5225000-5226000 |
| Year: | 2022 |
| Title: | Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 35849129 |
| MONDO: | MONDO:0001156 |
| Tissue: | Cervix |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | cervical adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | CUT&RUN |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, RT-RT-qPCR, 3C-RT-qPCR, Western blot |
| Target gene : | HBG1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01640 | chr11:5225000-5226000 | Embryonic Kidney | embryonic kidney cell | -- |
| E_01642 | chr11:5225000-5226000 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_01643 | chr11:5225000-5226000 | Bone | osteosarcoma cell | osteosarcoma |
| E_01808 | chr11:5225440-5225500 | Bone Marrow | hematopoietic stem cell | -- |